Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
835M
-
Number of holders
-
166
-
Total 13F shares, excl. options
-
18M
-
Shares change
-
+428K
-
Total reported value, excl. options
-
$952M
-
Value change
-
+$24.4M
-
Put/Call ratio
-
0.78
-
Number of buys
-
72
-
Number of sells
-
-70
-
Price
-
$53.01
Significant Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q2 2020
182 filings reported holding RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share as of Q2 2020.
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) has 166 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18M shares
of 835M outstanding shares and own 2.15% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (2.35M shares), GOLDMAN SACHS GROUP INC (1.43M shares), VANGUARD GROUP INC (1.05M shares), BlackRock Inc. (1.03M shares), STATE STREET CORP (1.02M shares), DIMENSIONAL FUND ADVISORS LP (813K shares), Aperio Group, LLC (758K shares), SCHRODER INVESTMENT MANAGEMENT GROUP (562K shares), Parametric Portfolio Associates LLC (521K shares), and Grantham, Mayo, Van Otterloo & Co. LLC (450K shares).
This table shows the top 166 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.